MBody AI (MBAI) vs Koninklijke Philips N.V. NY Registry Shares (PHG)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Koninklijke Philips N.V. NY Registry Shares (PHG) has outperformed MBody AI (MBAI) over the past year, losing 13.4% versus a loss of 78.5%. Over five years, PHG leads with a -46.0% price change compared with -97.3% for MBAI. Koninklijke Philips N.V. NY Registry Shares is the larger company by market cap ($23.64 billion vs $45.9 million), about 515.2 times the size.
On valuation, MBody AI trades at a lower trailing P/E (0.6x vs 18.0x for Koninklijke Philips N.V. NY Registry Shares). Koninklijke Philips N.V. NY Registry Shares pays a dividend yielding 3.51%, while MBody AI does not currently pay one.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | MBAI | PHG |
|---|---|---|
| Share price | $3.00 | $24.19 |
| Market cap | $45.88M | $23.64B |
| 1-day change | -6.54% | +0.39% |
| YTD return | -71.69% | -11.04% |
| 1-year return | -78.47% | -13.44% |
| 5-year return | -97.25% | -45.95% |
| P/E ratio (TTM) | 0.65 | 18.05 |
| Forward P/E | — | 12.77 |
| EPS (TTM) | $4.65 | $1.34 |
| Dividend yield | 0.00% | 3.51% |
| Annual dividend | $0.00 | $0.85 |
| 52-week high | $27.44 | $33.44 |
| 52-week low | $3.00 | $23.62 |
| Distance from 52-week high | -89.07% | -27.68% |
| Analyst consensus | — | hold |
| Avg. price target upside | — | +32.40% |
| Average volume | 20.77K | 994.93K |
| Shares outstanding | 15.29M | 977.43M |
| Employees | — | 63,670 |
| Sector | Health Care | Health Care |
| Industry | Medical Electronics | Medical Electronics |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- Koninklijke Philips N.V. NY Registry Shares is about 515.2 times larger than MBody AI by market value ($23.64B vs $45.88M).
- PHG has outperformed MBAI by 65.0 percentage points over the past year.
- Koninklijke Philips N.V. NY Registry Shares trades at a higher earnings multiple (18.0x vs 0.6x trailing P/E).
- Koninklijke Philips N.V. NY Registry Shares offers a meaningfully higher dividend yield (3.51% vs 0.00%).
About Koninklijke Philips N.V. NY Registry Shares
PHG stock →Koninklijke Philips N.V. operates as a health technology company in North America, the Greater China, and internationally.
Health Care · Medical Electronics · 63,670 employees
MBAI vs PHG FAQ
Which is bigger, MBody AI or Koninklijke Philips N.V. NY Registry Shares?
Koninklijke Philips N.V. NY Registry Shares (PHG) is larger, with a market capitalization of $23.64B compared with $45.88M for MBody AI (MBAI).
Which stock has performed better over the past year, MBAI or PHG?
PHG returned -13.44% over the past 12 months, compared with -78.47% for MBAI (price return, excluding dividends). Past performance does not predict future results.
Which has the lower P/E ratio, MBAI or PHG?
MBAI has the lower trailing P/E at 0.6, versus 18.0 for PHG. A lower P/E is not by itself a sign of a better investment; it can reflect slower expected growth or higher risk.
Which pays a higher dividend, MBody AI or Koninklijke Philips N.V. NY Registry Shares?
Koninklijke Philips N.V. NY Registry Shares pays a dividend yielding 3.51%, while MBody AI does not currently pay a regular dividend.
Are MBody AI and Koninklijke Philips N.V. NY Registry Shares in the same industry?
Yes. Both are classified in the Medical Electronics industry within the Health Care sector.